Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04903223 · ClinicalTrials.gov registry record · Phase 1
Liver Adiposity Effects on Pediatric Statin
A Phase 1 study of Cholesterol; Lipidosis, sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04903223 is a Phase 1 study of Cholesterol; Lipidosis that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04903223, a Phase 1 study of Cholesterol; Lipidosis, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin
Conditions Studied
Interventions
- DRUG Rosuvastatin 10mg
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04903223
The ClinicalTrials.gov registry entry for NCT04903223 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cholesterol; Lipidosis appearing as the primary indexed condition, and to 1 intervention - of which Rosuvastatin 10mg is the first listed.
NCT04903223 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04903223 about?
NCT04903223 is a clinical study titled "Liver Adiposity Effects on Pediatric Statin". Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed ro...
What is the current status of trial NCT04903223?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2021-04-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04903223 study?
This clinical trial studies the following conditions: Cholesterol; Lipidosis.
What interventions are being tested in trial NCT04903223?
The interventions under investigation include: Rosuvastatin 10mg (DRUG).
Who is sponsoring clinical trial NCT04903223?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04903223 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.